Tetracyclic peptides via a novel ‘Triple-C locking’ technology

Congratulations to our scientists!

Pepscan’s scientists have developed a brand-new technology for the synthesis of highly constrained tetracyclic peptides in a collaborative project together with the University of Amsterdam, EnzyPep B.V. and Maastricht University. The method is based on the cyclization of linear peptides via a one-pot ‘Triple-C (CEPS/CLIPS/CuAAC) locking’ procedure, thereby enabling the general and facile production of isomerically pure tetracyclic peptides. The authors have reported their findings in the peer-reviewed journal ChemBioChem.

Tetracyclic Peptide and / or Cyclized Peptide

The authors believe that the novel ‘Triple-C locking’ technology further enhances the toolbox for engineering multicyclic peptides and subsequently supports the development of therapeutic multicyclic peptides.

More information can be found in the main article: Richelle et al.: A One‐Pot “Triple‐C” Multicyclization Methodology for the Synthesis of Highly Constrained Isomerically Pure Tetracyclic Peptides, 2018, https://doi.org/10.1002/cbic.201800346

We use cookies to ensure that we give you the best experience on our website. We also use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on the Pepscan website. However, if you would like to, you can change your cookie settings at any time in your browser.
Cookie Policy
Find out more
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Cookie Settings
Accept All Cookies